Form 4: Elanco Animal Health Executive Rajeev A. Modi Reports Acquisition of Deferred Stock Units
SEC Form 4 Filing
Elanco Animal Health's Executive Vice President, Rajeev A. Modi, reports acquiring deferred stock units convertible to common stock or cash.
Summary
- On February 23, 2024, Rajeev A. Modi, an Executive Vice President at Elanco Animal Health Inc., acquired deferred stock units.
- The transaction involved 76.6035 deferred stock units, each representing the right to receive one share of Elanco common stock or the cash equivalent.
- These deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.
- Following the reported transaction, Modi directly owns 318.3775 shares of Elanco common stock.
- The price of the deferred stock units was $16.37.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding executive compensation, and does not contain information that would significantly impact investor sentiment.
Future Outlook
The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Industry Context
Executive compensation in the animal health industry often includes stock-based awards to align management's interests with those of shareholders. Deferred stock units are a common component of these packages.
Stakeholder Impact
- The acquisition of deferred stock units by an executive aligns their interests with shareholders, potentially incentivizing performance that benefits the company.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Date of transaction: Rajeev A. Modi acquired deferred stock units. |
| 02/27/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.